Cancer / Immunology
Ascentage Pharma's Three Studies Highlight New Potential Indications
"The data we presented at this year's AACR Annual Meeting highlight the three drug candidates' potential for clinical development and promising syn...
April 18, 2023 | News
Roche's Tecentriq plus Avastin Reduces Cancer Return Risk in Phase III Liver Cancer Study
In the first-ever positive Phase III trial in the adjuvant hepatocellular carcinoma (HCC) setting, Tecentriq plus Avastin reduced the...
April 17, 2023 | News
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
"We at ImmunOs are very satisfied with the work done by ProBioGen. We highly appreciate the collaborative partnership with ProBioGen and the team's dedicat...
April 13, 2023 | News
Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics
The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...
April 12, 2023 | News
BGI Global's Colorectal Cancer Survey uncovers gaps in awareness and concerns over affordability
This inaugural report seeks to better understand the global state of CRC awareness, as well as attitudes and actions towards CRC screening for average risk...
April 07, 2023 | News
Chula Develops CAR T-Cell Therapy for Thai Lymphoma Patients
Chulalongkorn University and the Faculty of Medicine, Chulalongkorn University, organized the 17th Chula the Impact on "CAR T-Cell Canc...
April 06, 2023 | News
Roche Diagnostics India Unveils #BeYourOwnShero Campaign to Educate Women About Cervical Cancer Prevention
Cervical Cancer is India’s second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. D...
April 05, 2023 | News
Pfizer Invests $43 Billion to Battle Cancer
Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...
March 14, 2023 | News
Akeso, based in Hong Kong, completes patient enrollment for Phase III clinical trial of Cadonilimab in the treatment of gastric cancer.
Akeso, Inc. (9926.HK) announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab (PD-1/CTLA-4 bi-sp...
March 14, 2023 | News
Qritive and Corista Partner to Advance Computational Digital Pathology Workflows with Integrated Image Management"
Through the partnership, Qritive's artificial intelligence modules and Corista's DP3® image management platform will be integrated to help pathologist'...
March 14, 2023 | News
Porton Advanced and Bennu Biotherapeutics Partner to Develop Cell Therapy for Solid Tumors
As an end-to-end gene and cell therapy service CDMO, Porton Advanced provides comprehensive solutions covering plasmids, cell therapy, gene therapy, oncoly...
March 13, 2023 | News
Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EAU
Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...
March 09, 2023 | News
Hummingbird Bioscience licenses Cancer Research UK's clinical trial results to support HMBD-001 development.
The Phase 1/2a clinical trial in the United Kingdom is being sponsored and managed by CRUK's Centre for Drug Development and led by Chief Investi...
March 06, 2023 | News
C2i Genomics Expands to Japan, Announces Collab with Riken Genesis
The collaboration will expand C2i’s global reach and bring MRD cancer monitoring capabilities for solid tumors to Japan C2i Genomics...
March 03, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
